H1B Report
Side-by-side comparison

Deloitte Consulting LLP vs Fox Chase Cancer Center Medical Group

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Deloitte Consulting LLP
PARank #4FEIN 06-1454513

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricDeloitte Consulting LLPFox Chase Cancer Center Medical Group
Total filings80,813130
Certified %98.23%55.38%
Denied %1.09%35.38%
Withdrawn %0.61%6.15%
Cert-withdrawn %0.07%3.08%
Rank#4
Active yearsFY2010–FY2026FY2010–FY2021
Worksite statePAPA

Outcomes — Deloitte Consulting LLP

DOL case-status mix.

Outcome breakdown: Certified 98.2%, Cert-withdrawn 0.1%, Withdrawn 0.6%, Denied 1.1%
Outcome breakdown
OutcomeShare
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%

Outcomes — Fox Chase Cancer Center Medical Group

DOL case-status mix.

Outcome breakdown: Certified 55.4%, Cert-withdrawn 3.1%, Withdrawn 6.2%, Denied 35.4%
Outcome breakdown
OutcomeShare
Certified55.4%
Cert-withdrawn3.1%
Withdrawn6.2%
Denied35.4%
Certified55.4%
Cert-withdrawn3.1%
Withdrawn6.2%
Denied35.4%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Deloitte Consulting LLP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,375
FY20113,610
FY20124,716
FY20136,082
FY20147,007
FY20157,572
FY20167,629
FY20177,147
FY201816,089
FY20197,754
FY202052
FY202135
FY202211
FY20231,134
FY20242,702
FY20254,286
FY20262,612
Fox Chase Cancer Center Medical Group
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY201068
FY201118
FY201235
FY20131
FY20141
FY20150
FY20162
FY20170
FY20182
FY20191
FY20201
FY20211
FY20220
FY20230
FY20240
FY20250
FY20260

Top 5 occupations — Deloitte Consulting LLP

Top 5 occupations — Fox Chase Cancer Center Medical Group

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.